To assess this, we downloaded data from the TIP database and evaluated the activity scores of the cancer immunity cycle using the GSVA algorithm, discovering a positive correlation between high R3HDM1 expression and the release of cancer cell antigens (step 1), recruitment of Th1 cells (step 4), and T cell recognition of cancer cells (step 6). This evidence concerns the gene R3HDM1 and cancer.